Assessing Readability of US Food and Drug Administration-Required Labeling for Breast Implants

Plast Reconstr Surg. 2024 May 1;153(5):1050e-1052e. doi: 10.1097/PRS.0000000000011091. Epub 2023 Sep 26.
No abstract available

MeSH terms

  • Breast Implantation
  • Breast Implants* / adverse effects
  • Comprehension*
  • Female
  • Humans
  • Product Labeling* / standards
  • United States
  • United States Food and Drug Administration* / standards